Previous Page  3 / 25 Next Page
Information
Show Menu
Previous Page 3 / 25 Next Page
Page Background

Page 47

Notes:

allied

academies

September 20-22, 2017 | Toronto, Canada

10

TH

AMERICAN PEDIATRICS HEALTHCARE &

PEDIATRIC INFECTIOUS DISEASES CONGRESS

Pediatric Healthcare & Pediatric Infections 2017

I

n humans, genetic defects of the synthesis or regeneration

of tetrahydrobiopteridin (BH4), an essential cofactor

in hydroxylation reactions, are associated with severe

neurological disorders. The diagnosis of these conditions

relies on the determination of BH4, and its metabolites

and precursors in biological fluids. This paper describes a

reversed-phase high-performance liquid chromatographic

(HPLC), new method with fluorometric detection (ERRECI,

Milano) for precise and sensitive quantification in urine

of the pterins after oxidation: neopterin, monapterin,

isoxanthopterin, pterin, biopterin and primapterin. The HPLC

method employs a C18, 5-

µ

m particle size analytical column

(250 mm×4.6 mm), 10-

µ

L injection volume, column at room

temperature, excitation at 350 nm and emission at 450 nm,

and an acetate buffer mobile phase at a flow rate of 1.1 mL/

min. These conditions resolve the six molecules as well as

diluent peaks within 20 min. The method is linear for all the

six molecules (0.2-34.0

µ

mol/L). The detection limits were

<0.08

µ

mol/L at a signal-to-noise ratio of two. The relative

standard deviation was <5% (<10% only for monapterin)

for the within-assay imprecision (n=10) and <9% for the

between-assay imprecision (n=6). The recovery of different

amount (1.3-5.5

µ

mol/L) of the six molecules added to

an urine sample was 92-108%. The specific and sensitive

method described may offer a means for determining

BH4 and five metabolites. The method is characterized by

high recovery and good reproducibility; it is well suited for

routine operation in every newborn with even slight but

persistent hyperphenylalaninemia unresponsive to a low-

phenylalanine diet.

Speaker Biography

A Barassi has completed her PhD from Insubria University School of Medicine (Varese,

Italy) and Post-doctoral studies from Insubria University School of Medicine (Varese,

Italy). She is working as an Assistant Professor of Clinical Biochemistry and Clinical

Molecular Biology, University of Milan from 2006 and Assistant of Laboratory of Clinical

Chemistry, San Paolo University Hospital, Milan, Italy from 2007. She has published

67 papers in reputed journals and has been serving as an Editorial Board Member of

repute.

e:

alessandra.barassi@unimi.it

Determination of pterines as markers of hyperphenylalaninemias

Alessandra Barassi

1

, C A L Damele

2

, R Stefanelli

2

, M Di Dario

2

, L Massaccesi

1

and

G V Melzi d’Eril

1

1

Università degli Studi di Milano, Italy

2

ASST Santi Paolo e, Italy